0HCK.L

Align Technology, Inc. [0HCK.L] Stock Forecast

Q: What is Align Technology, Inc. stock symbol ?

Align Technology, Inc. is a US stock, located in Tempe of Az and trading under the symbol 0HCK.L

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

0HCK.L Stock Summary

EPS has been increasing for the past 3 quarters (Quarter statements)

0HCK.L has more than 203 years of cash runway (2439 months)

Earnings are expected to fall -100% next year

Profit margins (0.1%) are lower than the previous year (0.12%)

Top 10 Correlated Stocks

0HCK.L

In the News

0HCK.L Financial details

Company Rating

Strong Buy

Market Cap

23.58B

Income

445.05M

Revenue

3.86B

Book val./share

47.96

Cash/share

12.85

Dividend

Dividend %

Employees

21.61K

Optionable

Shortable

Yes

Earnings

24 Apr 2024

P/E

56.8

Forward P/E

PEG

21.69

P/S

5.2

P/B

5.42

P/C

23.27

P/FCF

28.85

Quick Ratio

1.03

Current Ratio

1.27

Debt / Equity

-0

LT Debt / Equity

EPS (TTM)

5.83

EPS next Y

EPS next Q

EPS this Y

25.97%

EPS next Y

EPS next 5Y

EPS last 5Y

0.88%

Revenue last 5Y

9.92%

Revenue Q/Q

-0.36%

EPS Q/Q

3.14%

SMA20

-2.83%

SMA50

10.75%

SMA100

46.45%

Inst Own

Inst Trans

ROA

ROE

10%

ROC

0.14%

Gross Margin

70%

Oper. Margin

16%

Profit Margin

10%

Payout

Shs Outstand

Shs Float

Target Price

52W Range

176.8-411.5347

52W High

-27.26%

52W Low

+69.88%

RSI

Rel Volume

0.64

Avg Volume

944

Volume

602

Perf Week

-8.01%

Perf Month

-4.17%

Perf Quarter

56.39%

Perf Half Y

9.11%

Beta

1.642

Volatility

4.12%, 8.1%

Prev Close

-1.08%

Price

298.98

Change

-1.75%

0HCK.L Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	30.3	31.39	50.09	47.76	50.54
Net income per share	5.57	22.55	9.78	4.62	5.82
Operating cash flow per share	9.41	8.41	14.86	7.27	10.28
Free cash flow per share	7.52	6.44	9.78	3.54	10.28
Cash per share	10.94	12.2	14.84	12.78	12.73
Book value per share	16.95	41.06	45.91	46.06	47.5
Tangible book value per share	16	33.76	39.21	39.62	42.01
Share holders equity per share	16.95	41.06	45.91	46.06	47.5
Interest debt per share	0.2	0.28	0.29	0.34	0
Market cap	40.1B	39.77B	39.85B	16.18B	21.01B
Enterprise value	39.61B	38.89B	38.87B	15.37B	20.17B
P/E ratio	90.57	22.39	51.62	44.76	47.21
Price to sales ratio	16.66	16.09	10.08	4.33	5.44
POCF ratio	53.67	60.06	33.98	28.45	26.74
PFCF ratio	67.11	78.4	51.65	58.46	26.74
P/B Ratio	29.79	12.3	11	4.49	5.79
PTB ratio	29.79	12.3	11	4.49	5.79
EV to sales	16.46	15.73	9.84	4.11	5.22
Enterprise value over EBITDA	64.11	77.3	34.96	18.96	30.69
EV to operating cash flow	53.01	58.74	33.15	27.02	25.67
EV to free cash flow	66.29	76.68	50.39	55.51	25.67
Earnings yield	0.01	0.04	0.02	0.02	0.02
Free cash flow yield	0.01	0.01	0.02	0.02	0.04
Debt to equity	0.01	0.01	0.01	0.01	0
Debt to assets	0.01	0	0	0	0
Net debt to EBITDA	-0.8	-1.74	-0.88	-1.01	-1.28
Current ratio	1.68	1.4	1.3	1.26	1.18
Interest coverage	0	0	0	0	0
Income quality	1.69	0.37	1.52	1.57	1.77
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	0.4	0	0	0	0
Research and developement to revenue	0.07	0.07	0.06	0.08	0.09
Intangibles to total assets	0.03	0.12	0.09	0.08	0.07
Capex to operating cash flow	-0.2	-0.23	-0.34	-0.51	0
Capex to revenue	-0.06	-0.06	-0.1	-0.08	0
Capex to depreciation	-1.45	-1.34	-2.96	-1.87	0
Stock based compensation to revenue	0.04	0.04	0.03	0.04	0
Graham number	46.11	144.33	100.52	69.23	78.89
ROIC	0.29	0.55	0.2	0.11	0.12
Return on tangible assets	0.18	0.42	0.14	0.07	0.08
Graham Net	2.97	-0.43	-4.56	-5.47	-8.57
Working capital	662.45M	523.94M	570M	498.5M	380.01M
Tangible asset value	1.27B	2.66B	3.09B	3.1B	3.21B
Net current asset value	478.89M	253.72M	174.68M	77.8M	-6.77M
Invested capital	0.01	0.01	0.01	0.01	0
Average receivables	529.99M	664.67M	802.78M	948.68M	951.8M
Average payables	75.75M	114.69M	153.01M	145.88M	120.5M
Average inventory	83.85M	125.64M	184.73M	284.49M	317.83M
Days sales outstanding	94.17	104.59	82.85	97.75	85.38
Days payables outstanding	48.96	74.52	59.88	43.04	36.11
Days of inventory on hand	62.87	73.01	84.12	114.02	94.77
Receivables turnover	3.88	3.49	4.41	3.73	4.28
Payables turnover	7.46	4.9	6.1	8.48	10.11
Inventory turnover	5.81	5	4.34	3.2	3.85
ROE	0.33	0.55	0.21	0.1	0.12
Capex per share	-1.88	-1.97	-5.08	-3.73	0

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric	2022-12-31	2023-03-31	2023-06-30	2023-09-30	2023-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	11.63	12.26	13.1	12.54	12.64
Net income per share	0.54	1.14	1.46	1.59	1.64
Operating cash flow per share	1.87	2.6	3.29	3.75	0.62
Free cash flow per share	1.18	1.77	2.53	3.47	0.62
Cash per share	12.89	11.49	13.17	16.77	12.85
Book value per share	46.44	45.24	47.54	49.65	47.96
Tangible book value per share	39.95	38.64	40.96	43.29	42.42
Share holders equity per share	46.44	45.24	47.54	49.65	47.96
Interest debt per share	0.34	0.36	0.38	0.37	0
Market cap	16.05B	25.11B	27.07B	23.67B	20.81B
Enterprise value	15.23B	24.41B	26.25B	22.56B	19.97B
P/E ratio	96.04	71.51	60.52	48.74	41.96
Price to sales ratio	17.8	26.63	27.01	24.66	21.76
POCF ratio	110.9	125.64	107.51	82.43	443.81
PFCF ratio	175.39	184.97	140.08	89.15	443.81
P/B Ratio	4.46	7.22	7.44	6.23	5.73
PTB ratio	4.46	7.22	7.44	6.23	5.73
EV to sales	16.9	25.88	26.19	23.5	20.88
Enterprise value over EBITDA	92	137.83	121.8	110.94	107.65
EV to operating cash flow	105.27	122.11	104.26	78.56	425.89
EV to free cash flow	166.48	179.77	135.85	84.96	425.89
Earnings yield	0	0	0	0.01	0.01
Free cash flow yield	0.01	0.01	0.01	0.01	0
Debt to equity	0.01	0.01	0.01	0.01	0
Debt to assets	0	0	0	0	0
Net debt to EBITDA	-4.92	-3.98	-3.8	-5.47	-4.53
Current ratio	1.26	1.16	1.17	1.27	1.18
Interest coverage	0	0	0	0	0
Income quality	3.46	2.28	2.25	2.37	0.38
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	0	0	0	0	0
Research and developement to revenue	0.09	0.09	0.09	0.09	0.09
Intangibles to total assets	0.08	0.09	0.08	0.08	0.07
Capex to operating cash flow	-0.37	-0.32	-0.23	-0.08	0
Capex to revenue	-0.06	-0.07	-0.06	-0.02	0
Capex to depreciation	-1.28	-1.47	-1.34	-0.58	0
Stock based compensation to revenue	0.04	0.04	0.04	0.04	0
Graham number	23.73	34.09	39.54	42.09	42.04
ROIC	0.01	0.02	0.03	0.03	0.04
Return on tangible assets	0.01	0.02	0.02	0.02	0.02
Graham Net	-5.51	-7.93	-7.29	-4.1	-8.65
Working capital	498.5M	327.28M	358.39M	578.82M	380.01M
Tangible asset value	3.1B	2.97B	3.13B	3.31B	3.21B
Net current asset value	77.8M	-89.52M	-40.79M	185.12M	-6.77M
Invested capital	0.01	0.01	0.01	0.01	0
Average receivables	995.93M	1.01B	1.04B	1.04B	965.79M
Average payables	133.39M	129.22M	120.36M	104.92M	106.41M
Average inventory	329.83M	325.32M	312.31M	304.46M	296.55M
Days sales outstanding	99.85	98.2	93.9	96.37	84.99
Days payables outstanding	41.29	42.27	34.95	30.7	35.88
Days of inventory on hand	109.38	100.98	99.22	91.22	94.17
Receivables turnover	0.9	0.92	0.96	0.93	1.06
Payables turnover	2.18	2.13	2.58	2.93	2.51
Inventory turnover	0.82	0.89	0.91	0.99	0.96
ROE	0.01	0.03	0.03	0.03	0.03
Capex per share	-0.69	-0.83	-0.77	-0.28	0

0HCK.L Frequently Asked Questions

What is Align Technology, Inc. stock symbol ?

Align Technology, Inc. is a US stock , located in Tempe of Az and trading under the symbol 0HCK.L

What is Align Technology, Inc. stock quote today ?

Align Technology, Inc. stock price is $298.98 today.

Is Align Technology, Inc. stock public?

Yes, Align Technology, Inc. is a publicly traded company.

Something similar

Top by Market Cap

Same Sector

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 944
Market Capitalization 23.58B
Employee 21.61K
CEO Mr. Joseph M. Hogan
Headquarters Tempe,AZ,US
IPO Date 2018-01-29
Website https://www.aligntech.com

Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.